Search results for "net survival"

showing 10 items of 19 documents

Trends in net survival from 15 cancers in six European Latin countries: the SUDCAN population-based study material

2016

The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were c…

0301 basic medicineCancer Researchmedicine.medical_specialtyDatabases FactualEpidemiology03 medical and health sciences0302 clinical medicineBelgiumNeoplasmsEpidemiologymedicineHumansSurvival rateNet SurvivalSurvival analysisPortugalMortality ratePublic Health Environmental and Occupational HealthSurvival Analysis3. Good healthCancer registryEuropeSurvival RateTrend analysis030104 developmental biologyGeographyItalyOncologySpainPopulation Surveillance030220 oncology & carcinogenesisFranceDeath certificateSwitzerlandFollow-Up StudiesDemographyEuropean Journal of Cancer Prevention
researchProduct

Épidémiologie du cancer du pancréas

2018

Actually, pancreatic cancer is a major challenge in digestive oncology. Its prognosis remains very poor with a five-year net survival less than 10%. Although if pancreatic cancer incidence was low, data from French digestive cancer registries show a dramatic increase in recent years, more marked in women (annual variation of +3.6% between 1982 and 2012) than in men (+2.3%). The currently recognized risk factors like tobacco or obesity cannot explain this evolving epidemiology. Moreover, progress in understanding pancreatic carcinogenesis is still insufficient. Except for familial aggregation, systematic screening couldn't be proposed.

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtybusiness.industryIncidence (epidemiology)Family aggregationHematologyGeneral Medicinemedicine.diseaseObesity03 medical and health sciences030104 developmental biology0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinePancreatic cancerEpidemiologymedicineRadiology Nuclear Medicine and imagingPancreatic carcinogenesisAnnual variationbusinessNet SurvivalBulletin du Cancer
researchProduct

How do age and social environment affect the dynamics of death hazard and survival in patients with breast or gynecological cancer in France?

2021

Several studies have investigated the association between net survival and social inequalities in people with cancer, highlighting a varying influence of deprivation depending on the type of cancer studied. However, few of these studies have accounted for the effect of social inequalities over the follow-up period, and/or according to the age of the patients. Thus, using recent and more relevant statistical models, we investigated the effect of social environment on net survival in women with breast or gynecological cancer in France. The data were derived from population-based cancer registries, and women diagnosed with breast or gynecological cancer between 2006 and 2009 were included. We …

AdultCancer ResearchDeprivationGenital Neoplasms FemalePopulationBreast NeoplasmsAffect (psychology)03 medical and health sciencesNet survival0302 clinical medicineBreast cancerBreast cancerMedicineHumansSocial inequality030212 general & internal medicineRegistrieseducationAgedCervical cancerAged 80 and overeducation.field_of_studybusiness.industryAge FactorsSocial environmentCancerMiddle Agedmedicine.diseasePrognosis3. Good healthSurvival RateSocial environmentOncologySocioeconomic Factors030220 oncology & carcinogenesisGynecological cancerFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFrancebusinessOvarian cancerDemographyFollow-Up Studies
researchProduct

Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-based study.

2016

Rectal cancer is a common and serious disease. The aim of the SUDCAN collaborative study was to compare the net survival from rectal cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study-period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain, and Switzerland and from 2000 to 2004 in Belgium and Portugal. These analyses …

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentDatabases FactualEpidemiologyColorectal cancer03 medical and health sciencesYoung Adult0302 clinical medicineBelgiumEpidemiologymedicineHumansRegistriesYoung adultSurvival rateNet SurvivalMass screeningAgedExcess mortalityAged 80 and overPortugalbusiness.industryRectal NeoplasmsPublic Health Environmental and Occupational HealthMiddle Agedmedicine.disease3. Good healthPopulation based studyEuropeSurvival RateOncologyItalySpain030220 oncology & carcinogenesisPopulation Surveillance030211 gastroenterology & hepatologyFemaleFrancebusinessSwitzerlandDemographyEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
researchProduct

The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.

2014

Our specialized population-based registry has allowed us to explore changes in incidence and survival by subtype over the last 30 years. Between 1980 and 2009, 4790 cases of lymphoid malignancies were registered using the International Classification of Diseases for Oncology. The incidence rate of lymphoid malignancies was 20.5 per 100,000 inhabitants per year, and ranged from 0.1 to 4 according to subtype. Five-year net survival was 65%, and ranged from 41% to 93% according to subtype. We observed an increase in 5-year net survival between the periods 1980-1989 and 2000-2009 (58% vs. 70%). This was observed in most but not all subtypes. Our long-standing population-based registry allowed u…

AdultMaleCancer Researchmedicine.medical_specialtyAdolescentLymphomaPopulationYoung AdultSurvival probabilityInternal medicinemedicineHumansRegistrieseducationChildNet SurvivalAgedAged 80 and overeducation.field_of_studyLeukemiabusiness.industryIncidence (epidemiology)IncidenceHematologyMiddle AgedSurvival AnalysisCancer registryOncologyLymphoid malignancyChild PreschoolHematologic NeoplasmsPopulation SurveillanceImmunologyFemaleFrancebusinessPopulation-Based RegistryInternational Classification of Diseases for OncologyFollow-Up StudiesLeukemialymphoma
researchProduct

Time-to-cure and cure proportion in solid cancers in France. A population based study.

2019

In cancer care, the cure proportion (P) and time-to-cure (TTC) are important indicators for practitioners, patients, and healthcare policy makers. The recent definition of TTC as the time at which the probability of belonging to the cured group reaches 95% was used for the first time.The data stem from the common database of French cancer registries including 335,358 solid tumours diagnosed between 1995 and 2009 at 27 sites. P and TTC were estimated through a flexible parametric net survival cure model for each cancer site, sex, and age at diagnosis with acceptable assumption of cure (excess mortality rate ≤0.05).TTC was ≤5 years and P was80% for skin melanoma and thyroid and testis cancers…

AdultMaleCancer Researchmedicine.medical_specialtyDatabases FactualEpidemiology[SDV]Life Sciences [q-bio]03 medical and health sciences0302 clinical medicineInternal medicineNeoplasmsEpidemiologymedicineHumanscardiovascular diseases030212 general & internal medicineRegistriesNet SurvivalThyroid cancerAgedbusiness.industryThyroidCancerMiddle Agedmedicine.disease3. Good healthPopulation based studySurvival Ratemedicine.anatomical_structureOncology030220 oncology & carcinogenesisNational databaseFemaleFranceSkin melanomabusinessCancer epidemiology
researchProduct

Unbiased estimates of long-term net survival of solid cancers in France

2013

In cancer studies, net survival (observed if cancer was the only cause of death) is a useful indicator but survival estimation at 5 years is insufficient for planning healthcare needs. We estimated the net survivals at 5 and 10 years in a cohort of 387,961 patients who had solid tumors between 1989 and 2004 and were followed-up until January 1, 2008. The cases were actively followed-up. Net survival was estimated with the unbiased Pohar-Perme method. The standardized net survival used the international cancer survival standard weights. In men, the standardized net survivals ranged from 92% at 5 years and 89% at 10 years (testis) to 6% at 5 years and 5% at 10 years (pancreas). In women, it r…

AdultMaleCancer Researchmedicine.medical_specialty[SDV]Life Sciences [q-bio]03 medical and health sciences0302 clinical medicineBreast cancerAge DistributionBiasRisk FactorsNeoplasmsmedicineHumans030212 general & internal medicineRegistriesSex DistributionNet SurvivalSurvival analysisCause of deathAgedModels Statisticalbusiness.industrySurvival estimationAge FactorsCancerMiddle Agedmedicine.diseasePrognosisSurvival Analysis3. Good healthSurgeryOncology030220 oncology & carcinogenesisCancer managementCohortFemaleFrancebusinessDemography
researchProduct

Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study

2015

Abstract Background Traditionally, survival estimates have been reported as survival from the time of diagnosis. A patient's probability of survival changes according to time elapsed since the diagnosis and this is known as conditional survival. The aim was to estimate 5-year net conditional survival in patients with colorectal cancer in a well-defined French population at yearly intervals up to 5 years. Methods Our study included 18,300 colorectal cancers diagnosed between 1976 and 2008 and registered in the population-based digestive cancer registry of Burgundy (France). We calculated conditional 5-year net survival, using the Pohar Perme estimator, for every additional year survived afte…

AdultMaleOncologymedicine.medical_specialtyColorectal cancerPopulationStage iiConditional survivalInternal medicineStatisticsmedicineHumansIn patientRegistrieseducationNet SurvivalAgedNeoplasm StagingAged 80 and overeducation.field_of_studyHepatologybusiness.industryGastroenterologyCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisPopulation based studyFemaleFranceColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct

Socioeconomic Environment and Survival in Patients with Digestive Cancers: A French Population-Based Study

2021

Simple Summary Studies investigating the social gradient in digestive cancer survival are scarce, and the statistical methods used do not always consider important assumptions in survival analysis for adequate assessment. Using an ecological index (European Deprivation Index), we found a negative impact of social environment in digestive cancers net survival (especially for esophagus, stomach, bile ducts among females; colon and rectum for both sexes) and provided insight into how this social gradient in cancer survival builds up, and at what time of follow-up it appears. These results can guide clinical practice/public health actions to address social inequalities in survival by targeting …

Cancer ResearchColorectal cancerPopulationArticleBile duct cancerdeprivationmedicineFrench cancer registrieseducationSocioeconomic statusRC254-282education.field_of_studybusiness.industryBile ductStomachsocial gradientdigestive cancersNeoplasms. Tumors. Oncology. Including cancer and carcinogensSocial environmentCancermedicine.diseasemedicine.anatomical_structureOncologycancer net survivalbusinessdigestive cancers; cancer net survival; deprivation; social gradient; French cancer registriesDemographyCancers
researchProduct

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (…

2022

Abstract Background Survival is a key metric of the effectiveness of a health system in managing cancer. We set out to provide a comprehensive examination of worldwide variation and trends in survival from brain tumors in adults, by histology. Methods We analyzed individual data for adults (15–99 years) diagnosed with a brain tumor (ICD-O-3 topography code C71) during 2000–2014, regardless of tumor behavior. Data underwent a 3-phase quality control as part of CONCORD-3. We estimated net survival for 11 histology groups, using the unbiased nonparametric Pohar Perme estimator. Results The study included 556,237 adults. In 2010–2014, the global range in age-standardized 5-year net survival for…

Cancer ResearchOncologyNeurology (clinical)brain tumor international comparisons net survival population-based cancer registriesSettore MED/42 - Igiene Generale E Applicatabrain tumor ; international comparisons ; net survival ; population-based cancer registries
researchProduct